LYRA THERAPEUTICS INC (LYRA) Stock Earnings & Estimates
NASDAQ:LYRA - US55234L1052 - Common Stock
7.05 USD
+0.02 (+0.36%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.36M 368.97% | 1.558M 14.56% | 1.534M -1.54% | 775.965K -49.42% | 1.734M 123.46% | 11.694M 574.39% | 37.365M 219.52% | 65.586M 75.53% | 94.649M 44.31% | 112.16M 18.50% | 128.31M 14.40% | |
| EBITDA YoY % growth | -53.92M -26.51% | -65.25M -21.01% | -60.262M 7.64% | -17.707M 70.62% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -54.99M -26.07% | -65.528M -19.16% | -60.733M 7.32% | -37.539M 38.19% | -61.934M -64.99% | -59.131M 4.53% | -30.839M 47.85% | -11.488M 62.75% | 11.048M 196.17% | 23.033M 108.48% | 33.406M 45.04% | |
| Operating Margin | -4,043.38% | -4,205.91% | -3,959.13% | -4,837.73% | -3,571.76% | -505.66% | -82.53% | -17.52% | 11.67% | 20.54% | 26.04% | |
| EPS YoY % growth | -87.50 47.76% | -62.50 28.57% | -71.50 -14.40% | -9.25 87.06% | -9.79 -5.74% | -6.84 30.06% | -0.22 96.72% | 0.15 168.18% | 0.38 146.67% | 0.57 51.35% | 0.77 33.93% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -5.98 33.50% | -5.50 31.25% | -1.39 76.88% | -1.57 71.49% | -1.66 72.22% | -1.76 67.92% | -1.89 -36.03% | -1.80 -14.29% | -1.89 -13.50% | -1.65 6.36% |
| Revenue Q2Q % growth | 199.583K 2.35% | 175.695K -15.94% | 102K -44.26% | 102K -44.26% | 102K -48.89% | 102K -41.94% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -8.116M 15.80% | -8.668M 11.24% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -5.51 85.11% | -6.14 | 0.63 | 10.27% |
| Q1 2025 Q2Q % growth | -6.00 65.71% | -6.97 | 0.97 | 13.92% |
| Q4 2024 Q2Q % growth | -8.00 27.27% | -6.12 | -1.88 | -30.72% |
| Q3 2024 Q2Q % growth | -9.00 33.33% | -11.63 | 2.63 | 22.60% |
| Q2 2024 Q2Q % growth | -37.00 -131.25% | -16.73 | -20.27 | -121.19% |
| Q1 2024 Q2Q % growth | -17.50 20.45% | -13.36 | -4.14 | -30.97% |
| Q4 2023 Q2Q % growth | -11.00 42.11% | -16.07 | 5.07 | 31.53% |
| Q3 2023 Q2Q % growth | -13.50 32.50% | -16.22 | 2.72 | 16.76% |
| Q2 2023 Q2Q % growth | -16.00 25.58% | -21.59 | 5.59 | 25.89% |
| Q1 2023 Q2Q % growth | -22.00 18.52% | -18.62 | -3.38 | -18.18% |
| Q4 2022 Q2Q % growth | -19.00 63.81% | -21.11 | 2.11 | 10.01% |
| Q3 2022 Q2Q % growth | -20.00 52.94% | -22.44 | 2.44 | 10.87% |
| Q2 2022 Q2Q % growth | -21.50 49.41% | -19.00 | -2.50 | -13.17% |
| Q1 2022 Q2Q % growth | -27.00 10.00% | -46.67 | 19.67 | 42.14% |
| Q4 2021 Q2Q % growth | -52.50 -128.26% | -40.29 | -12.21 | -30.31% |
| Q3 2021 Q2Q % growth | -42.50 -73.47% | -37.49 | -5.02 | -13.38% |
| Q2 2021 Q2Q % growth | -42.50 -51.79% | -30.26 | -12.24 | -40.45% |
| Q1 2021 Q2Q % growth | -30.00 96.79% | -24.48 | -5.52 | -22.55% |
| Q4 2020 Q2Q % growth | -23.00 | -28.56 | 5.56 | 19.47% |
| Q3 2020 Q2Q % growth | -24.50 | -20.74 | -3.76 | -18.13% |
| Q2 2020 Q2Q % growth | -28.00 | -19.21 | -8.79 | -45.76% |
| Q1 2020 Q2Q % growth | -935.00 | -34.17 | -900.83 | -2,636.32% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 183K -69.40% | 174.675K | 8.325K | 4.77% |
| Q1 2025 Q2Q % growth | 183K -65.60% | 163.2K | 19.8K | 12.13% |
| Q4 2024 Q2Q % growth | 209K 43.15% | 216.495K | -7.495K | -3.46% |
| Q3 2024 Q2Q % growth | 195K -64.15% | 326.4K | -131.4K | -40.26% |
| Q2 2024 Q2Q % growth | 598K 30.57% | 356.796K | 241.204K | 67.60% |
| Q1 2024 Q2Q % growth | 532K 29.76% | 428.4K | 103.6K | 24.18% |
| Q4 2023 Q2Q % growth | 146K 1,360.00% | 396.576K | -250.576K | -63.18% |
| Q3 2023 Q2Q % growth | 544K 51.11% | 379.032K | 164.968K | 43.52% |
| Q2 2023 Q2Q % growth | 458K -13.58% | 139.403K | 318.597K | 228.54% |
| Q1 2023 Q2Q % growth | 410K -12.77% | 162.69K | 247.31K | 152.01% |
| Q4 2022 Q2Q % growth | 10K -96.30% | 154.836K | -144.836K | -93.54% |
| Q3 2022 Q2Q % growth | 360K 3,500.00% | 138.383K | 221.617K | 160.15% |
| Q2 2022 Q2Q % growth | 530K | 1.471M | -941K | -63.97% |
| Q1 2022 Q2Q % growth | 470K | 1.275M | -805K | -63.14% |
| Q4 2021 Q2Q % growth | 270K | 1.173M | -903K | -76.98% |
| Q3 2021 Q2Q % growth | 10K | 408K | -398K | -97.55% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 8.1% | -5767.5% | 36.37% | -1512.89% |
| Revenue | 13.93% | 86.35% | 7.03% | -33.73% |